NVS

#41
Novartis AG
154.35 USD
+0.25%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
153.96
154.50
Годовой диапазон
104.93
170.46
Дневное изменение
+0.25%
Месячное изменение
+0.19%
6-месячное изменение
+19.19%
Годовое изменение
+44.02%
Предыдущее закрытие
153.96
Открыть
154.09
Bid
Ask
Минимум
153.96
High
154.50
Объем
180
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 294.52 B
  • Employee 75 K
  • Founded 1996
  • CEO Vasant Narasimhan
  • Website www.novartis.com
  • Headquarter Switzerland
  • FIGI BBG000LYF3S8
  • Industry Technology
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты

Novartis AG

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.

Новости